Vol 27 No 2 December - The Indian Society for Parasitology
Vol 27 No 2 December - The Indian Society for Parasitology
Vol 27 No 2 December - The Indian Society for Parasitology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Journal of Parasitic Diseases<br />
<strong>Vol</strong>. <strong>27</strong> (2) Dec. 2003, pp. 119-123<br />
Effect of Dextran and Polyvinylpyrrolidone<br />
on the activity of enzymes released<br />
extracellulary by Trypanosoma brucei<br />
UKPONG I.G.**, OPARA K.N.*<br />
Department of Zoology, University of Ibadan,**<br />
Department of Zoology, University of Uyo, Nigeria*<br />
Trypanosoma brucei releases the enzymes acid phosphatase and peptidase extracellularly into<br />
phosphate/saline/glucose (PSG) pH 8.0 buffer, in which the organism is incubated in vitro at 4°c <strong>for</strong> 5-30<br />
minutes with lysosomotropic compounds dextran and polyvinylpyrrolidone (PVP). <strong>The</strong> effect of these<br />
compounds was evaluated on the activity of the two enzymes. Both compounds promoted a time-dependent<br />
release of acid phosphatase but inhibited the release of the peptidase. While dextran had no lethal effect on<br />
the survival of the trypanosomes after 30 minutes of incubation, PVP killed most of the parasites after 15<br />
minutes of exposure.<br />
Key words : Acid Phosphatase, Dextran, Enzyme Release, Peptidase, Proteases, PVP, Trypanosoma brucei<br />
INTRODUCTION<br />
platelet aggregation, blood coagulation and<br />
thrombocytopaenia (Nwagwu et al., 1989; Davis et al.,<br />
rypanosomes are flagellated protozoan parasites<br />
1974). Considering the importance of endocytosis-<br />
Tof medical and veterinary importance. In man and<br />
exocytosis in trypanosomes, inhibiting or inducing<br />
domestic animals they exhibit varying degree of<br />
these processes would be a step in the right direction<br />
pathogenicity. Chemotherapy is still regarded as the<br />
towards the development of effective chemomost<br />
promising approach to the treatment and control<br />
therapeutic agents and/or vaccines against<br />
of African trypanosomiasis. Endocytosis-Exocytosis<br />
trypanosomiasis. We had, previously shown that the<br />
is a cellular process that occurs widely in eukaryotic<br />
released proteases include proteolytic bands of Mr<br />
cells. It involves sequential <strong>for</strong>mation and fusion of<br />
200, 106, 93, 63, 48, 40 and 25 KDa among which are<br />
membrane-bound vesicles, during which time, the<br />
cysteine and trypsin-like serine proteases as well as<br />
macromolecules involved are sequestered or<br />
acid phosphatase (Okenu and Opara 1996; Ekpo et al.,<br />
compartmentalized in vesicles. This is an important<br />
1996 and Steiger et al, 1980). We have also<br />
feature that facilitates direct transfer of substances<br />
demonstrated that lysosomotropic drugs such as<br />
between the outer and inner cell environment chloroquine, retinal, swainsonine, dextran and<br />
(Silverstain et al., 1989' Blumenthal 1987; Albert et<br />
polyvinylpyrrolidone (PVP) inhibit or activate the<br />
al., 1989).<br />
release of these enzymes (Opara et al., 1994; Opara<br />
<strong>The</strong> processes of endocytosis-exocytosis occur and Okenu 1996). In this report we have evaluated the<br />
through the flagellar pocket in many species of effect of the uptake of dextran and PVP on the survival<br />
trypanosomes (Opperdoes et al., 1987; Langreth and of trypanosomes and the effect of these compounds on<br />
Balber 1975) <strong>for</strong> the secretion of proteases and nutrient the activity of two of the enzymes released by T. brucei<br />
uptake (Knowles et al., 1987; Nwagwu et al., 1988; namely acid phosphatase and peptidase.<br />
Huet et al., 1992, Webster and Marsh 1986; Okenu and<br />
Opara, 1996). <strong>The</strong> released protease(s) have been<br />
MATERIALS AND METHODS<br />
implicated in the pathology of the disease such as Fluorogenic peptide substrates with a carboxyl-<br />
terminal 7-amino-4-trifluoromethyl Coumarin (AFC)<br />
* Corresponding Author<br />
were purchased from Enzyme Systems Product<br />
Livermore, Ca, (USA) while 4-methylumbelliferyl